B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosis by Tianju Liu, Francina Gonzalez De Los Santos, Andrew E. Rinke, Chuling Fang, Kevin R. Flaherty, Sem H. Phan

Get full text

Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonar... by Colin H. Holtze, Elizabeth A. Freiheit, Susan L. Limb, John L. Stauffer, Karina Raimundo, Wayne T. Pan, Kevin R. Flaherty, Hyun J. Kim

Get full text

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis by Vincent Cottin, Steven D Nathan, Lisa Lancaster, Peter Smith, Kevin R Flaherty, Jürgen Behr, CQ Deng, Natalie Pearce, Heidi Bell, Leigh Peterson

Get full text

Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. by Shanna L Ashley, Meng Xia, Susan Murray, David N O'Dwyer, Ethan Grant, Eric S White, Kevin R Flaherty, Fernando J Martinez, Bethany B Moore

Get full text

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis by Abhimanyu Chandel, Christopher S. King, Rosalinda V. Ignacio, Jean Pastre, Oksana A. Shlobin, Vikramjit Khangoora, Shambhu Aryal, Alan Nyquist, Anju Singhal, Kevin R. Flaherty, Steven D. Nathan

Get full text

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry by Christopher S. King, Emily White, Shambhu Aryal, Oksana A. Shlobin, Anju Singhal, A. Whitney Brown, Christopher Thomas, Vikramjit Khangoora, Alan Nyquist, Kevin R. Flaherty, Steven D. Nathan, Joshua J. Mooney

Get full text

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial by Anna J. Podolanczuk, John S. Kim, Christopher B. Cooper, Joseph A. Lasky, Susan Murray, Justin M. Oldham, Ganesh Raghu, Kevin R. Flaherty, Cathie Spino, Imre Noth, Fernando J. Martinez, for the PRECISIONS Study Team

Get full text

A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. by Sameer R Oak, Lynne Murray, Athula Herath, Matthew Sleeman, Ian Anderson, Amrita D Joshi, Ana Lucia Coelho, Kevin R Flaherty, Galen B Toews, Darryl Knight, Fernando J Martinez, Cory M Hogaboam

Get full text

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry by Craig S Conoscenti, Lisa H Lancaster, Imre Noth, Laurie D Snyder, Christopher Mosher, Colin H Holtze, Kevin R Flaherty, Megan L Neely, Anne S Hellkamp, Shaun Bender, Joao A de Andrade, Timothy PM Whelan

Get full text

Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Del... by Franck F. Rahaghi, Zeenat Safdar, Anne Whitney Brown, Joao A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, Maria L. Padilla, Imre Noth, Mary Beth Scholand, Adrian Shifren, Steven D. Nathan

Get full text

Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study by Athol U. Wells, Simon L. F. Walsh, Ayodeji Adegunsoye, Vincent Cottin, Sonye K. Danoff, Anand Devaraj, Kevin R. Flaherty, Peter M. George, Kerri A. Johannson, Martin Kolb, Yasuhiro Kondoh, Andrew G. Nicholson, Sara Tomassetti, Elizabeth R. Volkmann, Kevin K. Brown

Get full text

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort by Jamie L. Todd, Richard Vinisko, Yi Liu, Megan L. Neely, Robert Overton, Kevin R. Flaherty, Imre Noth, L. Kristin Newby, Joseph A. Lasky, Mitchell A. Olman, Christian Hesslinger, Thomas B. Leonard, Scott M. Palmer, John A. Belperio, on behalf of the IPF-PRO Registry investigators

Get full text

Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease by Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty, Lisa R. Young

Get full text

Computational deconvolution of cell type-specific gene expression in COPD and IPF lungs reveals disease severity associations by Min Hyung Ryu, Jeong H. Yun, Kangjin Kim, Michele Gentili, Auyon Ghosh, Frank Sciurba, Lucas Barwick, Andrew Limper, Gerard Criner, Kevin K. Brown, Robert Wise, Fernando J. Martinez, Kevin R. Flaherty, Michael H. Cho, Peter J. Castaldi, Dawn L. DeMeo, Edwin K. Silverman, Craig P. Hersh, Jarrett D. Morrow

Get full text

Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy – the study of clinical efficacy of antimicrobial therapy strategy using pra... by Kevin J. Anstrom, Imre Noth, Kevin R. Flaherty, Rex H. Edwards, Joan Albright, Amanda Baucom, Maria Brooks, Allan B. Clark, Emily S. Clausen, Michael T. Durheim, Dong-Yun Kim, Jerry Kirchner, Justin M. Oldham, Laurie D. Snyder, Andrew M. Wilson, Stephen R. Wisniewski, Eric Yow, Fernando J. Martinez, For the CleanUP-IPF Study Team

Get full text

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry by Jamie L. Todd, Megan L. Neely, Robert Overton, Katey Durham, Mridu Gulati, Howard Huang, Jesse Roman, L. Kristin Newby, Kevin R. Flaherty, Richard Vinisko, Yi Liu, Janine Roy, Ramona Schmid, Benjamin Strobel, Christian Hesslinger, Thomas B. Leonard, Imre Noth, John A. Belperio, Scott M. Palmer, on behalf of the IPF-PRO Registry investigators

Get full text

Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study by Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim A. Wuyts, R. Gisli Jenkins, Mary Beth Scholand, Michael Kreuter, Claudia Valenzuela, Christopher J. Ryerson, Jonathan Goldin, Grace Hyun J. Kim, Marzena Jurek, Martin Decaris, Annie Clark, Scott M. Turner, Chris N. Barnes, Hardean E. Achneck, Gregory P. Cosgrove, Éric A. Lefebvre, Kevin R. Flaherty

Get full text

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease by Franck F. Rahaghi, Vivien M. Hsu, Robert J. Kaner, Maureen D. Mayes, Ivan O. Rosas, Rajan Saggar, Virginia D. Steen, Mary E. Strek, Elana J. Bernstein, Nitin Bhatt, Flavia V. Castelino, Lorinda Chung, Robyn T. Domsic, Kevin R. Flaherty, Nishant Gupta, Bashar Kahaleh, Fernando J. Martinez, Lee E. Morrow, Teng Moua, Nina Patel, Oksana A. Shlobin, Brian D. Southern, Elizabeth R. Volkmann, Dinesh Khanna

Get full text

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study by Luca Richeldi, Naomi Launders, Fernando Martinez, Simon L.F. Walsh, Jeffrey Myers, Bonnie Wang, Mark Jones, Alison Chisholm, Kevin R. Flaherty, REG IPF/ILD Working Group collaborators:, Aileen David-Wang, Antonio Morais, Arata Azuma, Bruno Crestani, Carlo Vancheri, Carole Youakim, Charlene D. Fell, Christopher J. Ryerson, Demosthenes Bouros, Elisabeth Bendstrup, Ferran Morell, Francesco Bonella, Ganesh Raghu, George Christoff, Giovanni Ferrara, Ian Glaspole, Ivan Rosas, Jürgen Behr, Kaissa DeBoer, Katerina M. Antoniou, Keertan Dheda, Kevin Brown, Lurdes Planas-Cerezales, Magnus Sköld, Manuela Funke, Maria Molina-Molina, Mariano Mazzei, Martin Kolb, Moises Selman, Paola Rottoli, Paolo Spagnolo, Pilar Rivera-Ortega, Sergey Avdeev, Silvia Quandrelli, Tamera J. Corte, Toby M. Maher, Vincent Cottin, Wim Wuyts, Zuo Jun Xu

Get full text

Acute exacerbations in patients with progressive pulmonary fibrosis by Michael Kreuter, Elizabeth A. Belloli, Elisabeth Bendstrup, Stefania Cerri, Kevin R. Flaherty, Shane Shapera, Jin Woo Song, Heiko Mueller, Klaus B. Rohr, Yasuhiro Kondoh, on behalf of the INBUILD trial investigators, S. Quadrelli, M. Otaola, M.A. Bergna, P. Elias, G. Arce, A. Cazaux, J. Guiot, B. Bondue, C. Dahlqvist, L. Homik, S. Shapera, A. Cantin, M. Kolb, M. Salinas Fénero, R. Maturana Rozas, A. Silva Orellana, Z. Xu, Q. Luo, J. Kang, H. Cai, S. Marchand-Adam, E. Bergot, A. Gamez-Dubuis, F. Riviere, R. Kessler, H. Nunes, C. Marquette, L. Wemeau, S. Jouneau, F. Lebargy, B. Crestani, V. Cottin, M. Reynaud-Gaubert, S. Blaas, F. Bonella, W. Randerath, J. Hetzel, D. Koschel, M. Kreuter, A. Prasse, D. Skowasch, S. Stieglitz, R. Refini, S. Cerri, A. Pesci, S. Tomassetti, C. Vancheri, F. Varone, N. Sakamoto, S. Abe, H. Hayashi, T. Saito, T. Suda, H. Kitamura, M. Okamoto, Y. Kondoh, S. Makino, T. Takeuchi, Y. Yamada, C. Kono, Y. Inoue, H. Sugiura, K. Kishi, H. Takaya, H. Yamauchi, K. Ichikado, K. Tomii, H. Takahashi, S. Izumi, T. Kawamura, Y. Nishioka, Y. Miyazaki, J.W. Song, J.S. Park, Y. Kim, E. Jassem, J. Kus, W. Piotrowski, A. Barczyk, D. Ziora, E. Bazdyrev, S. Moiseev, S. Avdeev, M. Ilkovich, V. Yakusevich, C. Valenzuela, O. Acosta, M. Martínez, L. Gómez, M. Molina-Molina, D.M. Castillo Villegas, M. Aburto, J.A. Rodríguez Portal, A. Villar, A. León Jiménez, J. Sauleda, M. Arias, P. Beirne, H. Stone, B. Hope-Gill, N. Hirani, N. Chaudhuri, A. Gifford, L. Jones, L. Morrison, D. Antin-Ozerkis, N. Bhatt, T. Kulkarni, T. Moua, N. Ettinger, L. Pitts, S. Veeraraghavan, M. Padilla, E.R. Fernández Pérez, G. Giessel, M. Strek, S. Danoff, J. Burk, M. Rossman, N. Patel, E. Belloli, D. Hotchkin, S. Weigt, M.B. Scholand, R. Kaner, B. Sigal, Z. Safdar, L. Tolle, R. Martinez, M. Glassberg, R. Hallowell, J. Golden, M. Schwartz, E. Britt, L. Morrow, Y. Mageto, K. Buch, S. Chaaban, H. Poonyagariyagorn, D. Dilling, O. Shlobin, K. Thavarajah, A. Nambiar, I. Rosas, R. Bascom, J. Oldham, S. Schmidt, J. Dematte D'Amico, J. Falk, C. Glazer, G. Criner

Get full text